Retrospective evaluation of efficacy of CytoSorb® therapy in septic shock patients in a tertiary care intensive care unit

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 4

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Critical Care Medicine

ISSN

2220-3141

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Crit Care Med. Dec 9, 2025; 14(4): 105600
Published online Dec 9, 2025. doi: 10.5492/wjccm.v14.i4.105600

Full Size Figure Download Figure

Figure 5 Treatment flowchart[11,21,29]. SOC: Standard of Care; NE: Norepinephrine; IL: Interleukin.

Citation: Shah MS, Sharma VV, Patel SJ, Ansari AS. Retrospective evaluation of efficacy of CytoSorb^® therapy in septic shock patients in a tertiary care intensive care unit. World J Crit Care Med 2025; 14(4): 105600
URL: https://www.wjgnet.com/2220-3141/full/v14/i4/105600.htm
DOI: https://dx.doi.org/10.5492/wjccm.v14.i4.105600

Shah MS, Sharma VV, Patel SJ, Ansari AS. Retrospective evaluation of efficacy of CytoSorb^® therapy in septic shock patients in a tertiary care intensive care unit. World J Crit Care Med 2025; 14(4): 105600 [PMID: 41377524 DOI: 10.5492/wjccm.v14.i4.105600]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.